Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression, Localization and Actions of Galectin-3: Implications in the Pathophysiology and Therapy of Cardiovascular Disease.

International journal of molecular sciences·2026
Same author

Dimethyl Fumarate Reverses β-Adrenoceptor-Mediated Myocardial Fibrosis in Mice by Inhibiting Yes-Associated Protein-Regulated Expression of Intermediate-Conductance Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel in Fibroblasts.

Journal of the American Heart Association·2026
Same author

S1PR1-MYPT1 Maintains Coronary Endothelial Barrier in Pressure-Overloaded Hearts.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Galectin-3 gene deletion alters lipid profile in healthy and cardiomyopathy mouse hearts.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2025
Same author

Development of a novel therapy for systolic heart failure.

EMBO molecular medicine·2025
Same author

Upregulating vascular endothelial K<sub>Ca</sub>2.3 channels alleviates pulmonary hypertension in mice.

Molecular pharmacology·2025

Related Experiment Video

Updated: Dec 22, 2025

Author Spotlight: Cardiac Cell Transgenesis for Rapid Gene Screening
05:06

Author Spotlight: Cardiac Cell Transgenesis for Rapid Gene Screening

Published on: May 24, 2024

1.1K

Gender modulates cardiac phenotype development in genetically modified mice.

Xiao-Jun Du1

  • 1Experimental Cardiology Laboratory, Wynn Domain, Baker Heart Research Institute PO Box 6492, Commercial Road, Melbourne, Victoria 3004, Australia. xiaojun.du@baker.edu.au

Cardiovascular Research
|July 28, 2004
PubMed
Summary

Sex differences in heart conditions are significant in mice. Female mice generally show better heart health and survival rates than males, influenced by hormones like estrogen.

More Related Videos

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
10:22

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse

Published on: October 26, 2017

22.4K
Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging
09:05

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging

Published on: June 21, 2016

18.8K

Related Experiment Videos

Last Updated: Dec 22, 2025

Author Spotlight: Cardiac Cell Transgenesis for Rapid Gene Screening
05:06

Author Spotlight: Cardiac Cell Transgenesis for Rapid Gene Screening

Published on: May 24, 2024

1.1K
Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
10:22

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse

Published on: October 26, 2017

22.4K
Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging
09:05

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging

Published on: June 21, 2016

18.8K

Area of Science:

  • Cardiovascular Research
  • Genetics
  • Endocrinology

Background:

  • Significant sex differences exist in cardiac phenotypes across various mouse strains.
  • Females typically exhibit lower mortality, reduced cardiac hypertrophy, and better preserved function compared to males.
  • Gender is recognized as an independent determinant of cardiac phenotype development in murine models.

Purpose of the Study:

  • To investigate the underlying mechanisms driving sex differences in cardiac phenotypes in genetically modified mice.
  • To explore the roles of estrogen and testicular hormones in cardiac protection and pathology.
  • To identify novel signaling pathways mediating these observed sex-based differences in the heart.

Main Methods:

  • Utilized genetically modified mouse models to study cardiac phenotypes.
  • Compared cardiac outcomes between male and female mice.
  • Analyzed hormonal influences, including estrogen and testicular hormones.
  • Investigated cardiac signaling mechanisms.

Main Results:

  • Females consistently demonstrated superior cardiac outcomes, including lower mortality and less severe pathology.
  • Estrogen appears to play a protective role in the female heart.
  • Testicular hormones may contribute to adverse cardiac effects observed in males.
  • Novel signaling pathways mediating sex differences in cardiac function were identified.

Conclusions:

  • Sex is a critical factor influencing cardiac phenotype development and disease progression in mice.
  • Hormonal factors, particularly estrogen and testicular hormones, are key mediators of these sex differences.
  • Further research into sex-specific signaling pathways can inform therapeutic strategies for cardiovascular diseases.